Anti-Fragilis IFITM3 Monoklonale antilichamen

Boster Bio Anti-Fragilis IFITM3 Monoclonal Antibody catalog # M02265. Tested in WB, IHC, ICC/IF, Flow Cytometry applications. This antibody reacts with Human.

Aryl hydrocarbon receptor nuclear translocator; ARNT protein; Class E basic helix-loop-helix protein 2; bHLHe2; Dioxin receptor, nuclear translocator; Hypoxia-inducible factor 1-beta; HIF-1-beta; HIF1-beta; ARNT; BHLHE2

IFITM3

10410

Q01628

Human

A synthesized peptide derived from human Fragilis

Clone: ADAC-9

Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable. .

WB, IHC, ICC, IF, Flow Cytometry

Developmental Biology, Germ Cell Markers, Germline Stem Cells, Reproduction, Stem Cells

Affinity-chromatography

0.5mg/ml

Liquid

Required for activity of the Ah (dioxin) receptor. This protein is required for the ligand-binding subunit to translocate from the cytosol to the nucleus after ligand binding. The complex then initiates transcription of genes involved in the activation of PAH procarcinogens. The heterodimer with HIF1A or EPAS1/HIF2A functions as a transcriptional regulator of the adaptive response to hypoxia.

Store at -20°C for one year. For short term storage and frequent use, store at 4°C for up to one month. Avoid repeated freeze-thaw cycles.

https://www.bosterbio.com/msds?sku=M02265

86636 MW

16 kDa

Aryl hydrocarbon receptor nuclear translocator

Nucleus.

Lysosome-associated membrane glycoprotein 2 (Lamp2)

Rabbit IgG

Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol, 0.4-0.5mg/ml BSA.